Greenstein Leonard M. (0001519692)

Mailing Address 24562 BELGREEN PLACE LAKE FOREST CA 92630 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Tarsus Pharmaceuticals, Inc. 0001819790 2020-10-15 officer: Chief Financial Officer ENDOLOGIX INC /DE/ 0001013606 2011-05-02 officer: VP Finance & Corp Controller

Items 1 - 36

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
D	2023-04-20		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	5000.0000	26785.0000	1	0001819790	Common Stock
D	2023-03-23		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	346.0000	31785.0000	3	0001819790	Common Stock
D	2023-03-22		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	332.0000	32131.0000	2	0001819790	Common Stock
D	2023-03-21		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	326.0000	32463.0000	1	0001819790	Common Stock
D	2023-03-20		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	333.0000	32789.0000	2	0001819790	Common Stock
D	2023-03-17		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	316.0000	33122.0000	1	0001819790	Common Stock
D	2023-03-16		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	313.0000	38438.0000	2	0001819790	Common Stock
D	2023-03-16		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	5000.0000	33438.0000	3	0001819790	Common Stock
D	2023-03-15		Tarsus Pharmaceuticals, Inc.	4	M-Exempt	--D	4462.0000	13388.0000	4	0001819790	Restricted Stock Units
A	2023-03-15		Tarsus Pharmaceuticals, Inc.	4	M-Exempt	--D	4462.0000	38751.0000	1	0001819790	Common Stock
A	2023-03-08		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	27160.0000	27160.0000	2	0001819790	Restricted Stock Units
A	2023-03-08		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	40097.0000	40097.0000	1	0001819790	Stock Option (right to buy)
D	2023-02-16		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	5000.0000	34289.0000	1	0001819790	Common Stock
D	2023-01-19		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	5000.0000	39289.0000	1	0001819790	Common Stock
D	2022-12-15		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	5000.0000	44289.0000	1	0001819790	Common Stock
D	2022-11-17		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	5000.0000	49289.0000	1	0001819790	Common Stock
D	2022-10-20		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	4877.0000	54412.0000	1	0001819790	Common Stock
D	2022-10-20		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	123.0000	54289.0000	2	0001819790	Common Stock
D	2022-09-15		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	5000.0000	59289.0000	1	0001819790	Common Stock
D	2022-08-18		Tarsus Pharmaceuticals, Inc.	4	S-Sale	--D	5000.0000	64289.0000	1	0001819790	Common Stock
A	2022-03-09		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	17850.0000	17850.0000	2	0001819790	Restricted Stock Units
A	2022-03-09		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	60846.0000	60846.0000	1	0001819790	Stock Option (right to buy)
A	2021-01-07		Tarsus Pharmaceuticals, Inc.	4	A-Award	--D	40999.0000	40999.0000	1	0001819790	Stock Option (right to buy)
D	2013-10-03		ENDOLOGIX INC /DE/	4	D-Return	--D	4750.0000	7250.0000	3	0001013606	Option to purchase
D	2013-10-03		ENDOLOGIX INC /DE/	4	D-Return	--D	14472.0000	1330.0000	1	0001013606	Common Stock
D	2013-10-03		ENDOLOGIX INC /DE/	4	D-Return	--D	13062.0000	19938.0000	2	0001013606	Option to purchase
D	2013-09-05	2013-09-05	ENDOLOGIX INC /DE/	4	D-Return	--D	1973.0000	15802.0000	1	0001013606	Common Stock
D	2013-05-28	2013-05-28	ENDOLOGIX INC /DE/	4	S-Sale	--D	1253.0000	16445.0000	1	0001013606	Common Stock
A	2012-09-09	2012-09-09	ENDOLOGIX INC /DE/	4/A	A-Award	--D	14472.0000	17108.0000	1	0001013606	Common Stock
A	2012-09-09	2012-09-09	ENDOLOGIX INC /DE/	4/A	A-Award	--D	14472.0000	17108.0000	1	0001013606	Common Stock
A	2012-09-09	2012-09-09	ENDOLOGIX INC /DE/	4	A-Award	--D	14472.0000	17108.0000	1	0001013606	Common Stock
A	2011-05-02		ENDOLOGIX INC /DE/	4	A-Award	--D	45000.0000	45000.0000	1	0001013606	Option to purchase
-	-		Tarsus Pharmaceuticals, Inc.	3	-	--D		67316.0000	1	0001819790	Common Stock
-	-		ENDOLOGIX INC /DE/	3	-	--D		0.0000	1	0001013606	Common Stock
-	-		Tarsus Pharmaceuticals, Inc.	3	-	--D			2	0001819790	Employee Stock Option (right to buy)
-	-		Tarsus Pharmaceuticals, Inc.	3	-	--D			3	0001819790	Employee Stock Option (right to buy)

http://www.sec.gov/cgi-bin/own-disp

---